Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Riding toward Selectivity: Optimization of Covalent 7-Azaindole-Based BMX Kinase Inhibitors.

Journal of medicinal chemistry·2026
Same author

Clinicopathological characteristics of patients with inoperable non-small cell lung cancer harboring circulating NRF2 pathway mutations.

The Journal of pathology·2026
Same author

Doing More with Less: Accurate and Scalable Ligand Free Energy Calculations by Focusing on the Binding Site.

Journal of chemical information and modeling·2026
Same author

Discovery of benzyl carbamate inhibitors of coronavirus M<sup>pro</sup> enzymes from a legacy collection of cysteine protease inhibitors.

Journal of enzyme inhibition and medicinal chemistry·2025
Same author

A Twist of Fate: The Helix-Turn-Helix Motif in <i>Pseudomonas aeruginosa</i> ExsA Can Allosterically Stabilize the Ligand-Binding Domain.

Journal of chemical information and modeling·2025
Same author

Design of 2-Aminobenzothiazole Derivatives Targeting Trypanosomatid PTR1 by a Multidisciplinary Fragment Hybridization Approach.

Journal of medicinal chemistry·2025

Related Experiment Video

Updated: Jul 17, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

322

Machine Learning-Boosted Docking Enables the Efficient Structure-Based Virtual Screening of Giga-Scale Enumerated

Toni Sivula1, Laxman Yetukuri2, Tuomo Kalliokoski3

  • 1School of Pharmacy, University of Eastern Finland, Kuopio FI-70211, Finland.

Journal of Chemical Information and Modeling
|September 1, 2023
PubMed
Summary

Machine learning (ML) strategies like HASTEN accelerate drug discovery by rapidly screening billions of compounds. HASTEN achieves 90% recall of top hits by docking only 1% of a library, drastically reducing screening time.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.2K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K

Related Experiment Videos

Last Updated: Jul 17, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

322
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.2K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Machine learning

Background:

  • Ultra-large screening libraries present challenges for traditional docking-based virtual screening.
  • Existing methods struggle with the scale of giga-scale compound libraries.

Purpose of the Study:

  • To evaluate the HASTEN tool for accelerating virtual screening of giga-scale libraries.
  • To assess HASTEN's efficiency in recalling top-scoring compounds for antibacterial and antiviral targets.

Main Methods:

  • Generated a brute-force docking baseline for 1.56 billion compounds using the Glide high-throughput virtual screening protocol.
  • Applied HASTEN, a machine learning-boosted strategy, to screen a small fraction (1%) of the library.
  • Investigated the impact of hydrogen bonding constraints on docking and ML predictions.

Main Results:

  • HASTEN achieved 90% recall of the top 1000 virtual hits by docking only 1% of the library for both antibacterial and antiviral targets.
  • Reduced required docking experiments by 99%, significantly shortening screening time.
  • Identified optimization potential in handling failed docking attempts for ML-boosted screening.

Conclusions:

  • HASTEN is a fast and robust tool for screening giga-scale libraries in drug discovery.
  • ML-boosted strategies offer significant advantages in throughput and efficiency over brute-force docking.
  • HASTEN facilitates unlocking vast chemical space for drug discovery campaigns.